TheScientificWorldJOURNAL, 2006 · DOI: 10.1100/tsw.2006.44 · Published: February 17, 2006
This study looks at how amikacin, an antibiotic, is used in spinal cord injury patients. It found that there's a lot of variation in how different hospitals and experts dose and monitor this drug. Some hospitals use it once a day, others multiple times. Some monitor drug levels in the blood, others don't. Experts also disagree on the best way to use amikacin in these patients. Because of these differences, the study suggests that there is a need for better guidelines on how to use amikacin in spinal cord injury patients to make sure it is both safe and effective.
Due to the significant variation in amikacin dosing and monitoring, standardized guidelines are needed for spinal cord injury patients.
There is a need to collect prospective information on amikacin's clinical and microbiological efficacy, as well as ototoxicity and nephrotoxicity.
Creation of a database to record amikacin therapy details, including dosing, serum concentrations, pharmacokinetic parameters, efficacy, and adverse events, is suggested.